SPECTRUM PHARMACEUTICALS INC (SPPI) Stock Analyst Earnings Estimates
NASDAQ:SPPI - Nasdaq - US84763A1088 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.114M | 74.844M 640.00% | 128.52M 71.72% | 197.79M 53.90% | 190.61M -3.63% | 282.06M 47.98% | 419.32M 48.66% | 504.95M 20.42% | 551.31M 9.18% | |||
| EBITDA YoY % growth | -149.74M -5.42% | -142.517M 4.82% | -72.449M 49.16% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -150M -5.34% | -142.803M 4.80% | -72.697M 49.09% | -38.283M 47.34% | 7.572M 119.78% | 52.56M 594.14% | 41.921M -20.24% | 79.908M 90.62% | 114.72M 43.57% | 139.67M 21.75% | 139.09M -0.42% | |
| Operating Margin | N/A | N/A | -718.78% | -51.15% | 5.89% | 26.57% | 21.99% | 28.33% | 27.36% | 27.66% | 25.23% | |
| EPS YoY % growth | -1.30 -20.37% | -1.04 20.00% | -0.42 59.62% | -0.05 88.67% | 0.13 371.42% | 0.31 139.46% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.03 80.00% | -0.01 91.50% | 0.00 106.79% | 0.01 151.00% | 0.01 130.00% | 0.02 300.00% | 0.03 800.90% |
| Revenue Q2Q % growth | 16.853M | 19.776M | 22.293M 120.42% | 23.881M 52.94% | 26.269M 55.87% | 28.897M 46.12% | 31.786M 42.58% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.106M 75.95% | -3.427M 84.14% | -1.415M 87.85% | 1.76M 136.14% | 3.907M 163.98% | 6.268M 282.93% | 8.867M 726.76% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -0.02 75.00% | -0.07 | 0.05 | 69.36% |
| Q4 2022 Q2Q % growth | -0.05 80.77% | -0.11 | 0.06 | 54.61% |
| Q3 2022 Q2Q % growth | -0.12 42.86% | -0.15 | 0.03 | 20.24% |
| Q2 2022 Q2Q % growth | -0.17 46.88% | -0.16 | -0.01 | -5.49% |
| Q1 2022 Q2Q % growth | -0.08 68.00% | -0.20 | 0.12 | 59.15% |
| Q4 2021 Q2Q % growth | -0.26 10.34% | -0.22 | -0.04 | -19.11% |
| Q3 2021 Q2Q % growth | -0.21 43.24% | -0.29 | 0.08 | 26.47% |
| Q2 2021 Q2Q % growth | -0.32 -14.29% | -0.26 | -0.06 | -23.03% |
| Q1 2021 Q2Q % growth | -0.25 30.56% | -0.32 | 0.07 | 22.19% |
| Q4 2020 Q2Q % growth | -0.29 17.14% | -0.30 | 0.01 | 1.96% |
| Q3 2020 Q2Q % growth | -0.37 -60.87% | -0.36 | -0.01 | -3.64% |
| Q2 2020 Q2Q % growth | -0.28 -21.74% | -0.32 | 0.04 | 13.13% |
| Q1 2020 Q2Q % growth | -0.36 -33.33% | -0.35 | -0.01 | -2.01% |
| Q4 2019 Q2Q % growth | -0.35 | -0.33 | -0.02 | -5.26% |
| Q3 2019 Q2Q % growth | -0.23 | -0.42 | 0.19 | 45.67% |
| Q2 2019 Q2Q % growth | -0.23 | -0.28 | 0.05 | 17.70% |
| Q1 2019 Q2Q % growth | -0.27 | -0.30 | 0.03 | 9.76% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | 15.615M | 11.188M | 4.427M | 39.57% |
| Q4 2022 Q2Q % growth | 10.114M | 9.098M | 1.016M | 11.17% |
| Q3 2021 Q2Q % growth | 527.003K | -527.003K | -100.00% | |
| Q3 2020 Q2Q % growth | 51K | -51K | -100.00% | |
| Q2 2020 Q2Q % growth | 61.2K | -61.2K | -100.00% | |
| Q1 2020 Q2Q % growth | 61.2K | -61.2K | -100.00% | |
| Q4 2019 Q2Q % growth | 255K | -255K | -100.00% | |
| Q3 2019 Q2Q % growth | 255K | -255K | -100.00% | |
| Q2 2019 Q2Q % growth | 102K | -102K | -100.00% | |
| Q1 2019 Q2Q % growth | 13.906M | -13.906M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 44.45% | 78.12% | 78.12% |
| Revenue | 0% | 40.01% | 47.89% | 47.89% |